Inflammatory bowel diseases and management considerations: Fertility and pregnancy

Current Gastroenterology Reports

Volumn 11, Issue 5, 2009, Pages 395-399

  Moscandrew, Maria ^a   Kane, Sunanda ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; FOLIC ACID; INFLIXIMAB; MERCAPTOPURINE; NATALIZUMAB; SALAZOSULFAPYRIDINE;

ABSENCE OF SIDE EFFECTS; ASTHMA; BRAIN MALFORMATION; CARDIOVASCULAR MALFORMATION; COLON CROHN DISEASE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TRANSPORT; ENTERITIS; FEMALE; FEMALE FERTILITY; HUMAN; IRRITABLE COLON; MALE FERTILITY; NEURAL TUBE DEFECT; OLIGOSPERMIA; PREGNANCY OUTCOME; PRENATAL PERIOD; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT; UROGENITAL TRACT MALFORMATION;

6-MERCAPTOPURINE; ANIMALS; AZATHIOPRINE; BREAST FEEDING; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY; GASTROINTESTINAL AGENTS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFERTILITY, FEMALE; INFLAMMATORY BOWEL DISEASES; META-ANALYSIS AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 70349508757     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0059-6     Document Type: Review

References (57)

1. Munkholm P: Crohn's disease - occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997, 44:287-302.
2. Andres PG, Friedman LS: Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999, 28:255-281, vii.
3. Baird DD, Narendranathan M, Sandler RS: Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990, 99:987-994.
4. Hudson M, Flett G, Sinclair TS, et al.: Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997, 58:229-237.
5. Waljee A, Waljee J, Morris AM, et al.: Threefold increased risk of infertility: A meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 2006, 55:1575-1580.
6. Wikland M, Jansson I, Asztely M, et al.: Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. Int J Colorectal Dis 1990, 5:49-52.
7. Olsen KO, Juul S, Bulow S, et al.: Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 2003, 90:227-231.
8. Mortier PE, Gambiez L, Karoui M: Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol 2006, 30:594-597.
9. Narendranathan M, Sandler RS, Suchindran CM, et al.: Male infertility in inflammatory bowel disease. J Clin Gastroenterol 1989, 11:403-406.
10. Levi AJ, Fisher AM, Hughes L, et al.: Male infertility due to sulphasalazine. Lancet 1979, 2:276-278.
11. Birnie GG, McLeod TI, Watkinson G: Incidence of sulphasalazine-induced male infertility. Gut 1981, 22:452-455.
12. Taffet SL, Das KM: Sulfasalazine. Adverse effects and desensitization. Dig Dis Sci 1983, 28:833-842.
13. Kjaergaard N, Christensen LA, Lauritsen JG, et al.: Effects of mesalazine substitution on salicylazosulfapyridineinduced seminal abnormalities in men with ulcerative colitis. Scand J Gastroenterol 1989, 24:891-896.
14. O'Morain C, Smethurst P, Dore CJ, et al.: Reversible male infertility due to sulphasalazine: Studies in man and rat. Gut 1984, 25:1078-1084.
15. Riley SA, Lecarpentier J, Mani V, et al.: Sulphasalazine induced seminal abnormalities in ulcerative colitis: Results of mesalazine substitution. Gut 1987, 28:1008-1012.
16. Chatzinoff M, Guarino JM, Corson SL, et al.: Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas. Dig Dis Sci 1988, 33:108-110.
17. DiPaolo MC, Paoluzi OA, Pica R, et al.: Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects. Dig Liver Dis 2001, 33:563-569.
18. Saxena AK, Dhungel S, Bhattacharya S, et al.: Effect of chronic low dose of methotrexate on cellular proliferation during spermatogenesis in rats. Arch Androl 2004, 50:33-35.
19. Shrestha S, Dhungel S, Saxena AK, et al.: Effect of methotrexate (MTX) administration on spermatogenesis: An experimental on animal model. Nepal Med Coll J 2007, 9:230-233.
20. Karbach U, Ewe K, Shramm P: Quality of semen in patients with Crohn's disease. Z Gastroenterol 1982, 20:314-320.
21. Hull MG, North K, Taylor H, et al.: Delayed conception and active and passive smoking. The Avon Longitudinal Study of Pregnancy and Childhood Study Team. Fertil Steril 2000, 74:725-733.
22. Laurent SL, Thompson SJ, Addy C, et al.: An epidemiologic study of smoking and primary infertility in women. Fertil Steril 1992, 57:565-572.
23. Kalyani R, Basavaraj PB, Kumar ML: Factors influencing quality of semen: a two year prospective study. Indian J Pathol Microbiol 2007, 50:890-895.
24. Emanuele MA, Emanuele NV: Alcohol's effects on male reproduction. Alcohol Health Res World 1998, 22:195-201.
25. El-Tawil AM: Zinc deficiency in men with Crohn's disease may contribute to poor sperm function and male infertility. Andrologia 2003, 35:337-341.
26. Morales M, Berney T, Jenny A, et al.: Crohn's disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 2000, 47:1595-1598.
27. Nielsen OH, Andreasson B, Bondesen S, et al.: Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983, 18:735-742.
28. Bush MC, Patel S, Lapinski RH, et al.: Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004, 15:237-241.
29. Fedorkow DM, Persaud DA Nimrod CA: Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989, 160:998-1001.
30. Cornish J, Tan E, Teare J: A meta-analysis on the influence of inflammatory bowel disease on pregnancy Gut 2007, 56:830-837.
31. Mahadevan U, Sandborn WJ, Li DK, et al.: Pregnancy outcomes in women with inflammatory bowel disease: A large community-based study from Northern California. Gastroenterology 2007, 133:1106-1112.
32. Norgård B, Pedersen L, Christensen LA, Sørensen HT: Therapeutic drug use in women with Crohn's disease and birth outcomes: A Danish nationwide cohort study Am J Gastroenterol 2007, 102:1406-1413.
33. Nguyen GC, Boudreau H, Harris ML, Maxwell CV: Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States Clin Gastroenterol Hepatol 2009, 7:329-334.
34. Riis L, Vind I, Politi P: Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2006, 101:1539-1545.
35. Reddy D, Murphy SJ, Kane SV: Relapses of inflammatory bowel disease during pregnancy: In-hospital management and birth outcomes. Am J Gastroenterol 2008, 103:1203-1209.
36. Mogadam M, Korelitz BI, Ahmed SW, et al.: The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol 1981, 75:265-269.
37. Beniada A, Benoist G, Maurel J, et al.: Inflammatory bowel disease and pregnancy: Report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod (Paris) 2005, 34:581-588.
38. Kane S, Lemieux N: The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005, 100:102-105.
39. US Food and Drug Administration: Food and Drug Administration categories for the use of medications in pregnancy. Regulations 1980:37434-37467.
40. Craxi A, Pagliarello F: Possible embryotoxicity of sulfasalazine. Arch Intern Med 1980, 140:1674.
41. Hoo JJ, Hadro TA, Von Behren P: Possible teratogenicity of sulfasalazine. N Engl J Med 1988, 318:1128.
42. Newman NM, Correy JF: Possible teratogenicity of sulphasalazine. Med J Aust 1983, 1:528-529.
43. Mogadam M, Dobbins WO 3rd, Korelitz BI, et al.: Pregnancy in inflammatory bowel disease: Effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981, 80:72-76.
44. Norgård B, Czeizel AE, Rockenbauer M, et al.: Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001, 15:483-486.
45. Rahimi R, Nikfar S, Rezaie A, Abdollahi M: Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A metaanalysis. Reprod Toxicol 2008, 25:271-275.
46. Park-Wyllie L, Mazzotta P, Pastuszak A, et al.: Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000, 62:385-392.
47. Beaulieu DB, Ananthakrishnan AN, Issa M: Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis 2009, 15:25-28.
48. Polifka JE, Ariedman JM: Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002, 65:240-261.
49. Norgärd B, Pedersen L, Christensen LA, et al.: Therapeutic drug use in women with Crohn's disease and birth outcomes: A Danish nationwide cohort study. Am J Gastroenterol 2007, 102:1406-1413.
50. Christensen LA, Dahlerup JF, Nielsen MJ: Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008, 28:1209-1213.
51. Kane SV, Acquah LA: Placental tranAport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 2009, 104:228-233.
52. Lichtenstein GR, Feagan BG, Cohen RD, et al.: Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006, 4:621-630.
53. Katz JA, Antoni C, Keenan GF, et al.: Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004, 99: 2385-2392.
54. Kane S, Ford J, Cohen R, Wagner C: Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol 2009, 43:613-616.
55. Coburn LA, Wise PE, Schwartz DA: The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy. Dig Dis Sci 2006, 51:2045-2047.
56. Mishkin DS, Van Deinse W, Becker JM, et al.: Successful use of adalimumab (Humira) for Crohn's disease in pregnancy. Inflamm Bowel Dis 2006, 12:827-828.
57. Vesga L, Terdiman JP, Mahadevan U: Adalimumab use in pregnancy. Gut 2005, 54:890.